Moxifloxacin NDC 55111-112

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-112Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0112Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-112-01	55111011201	100 TABLET, FILM COATED in 1 BOTTLE (55111-112-01)Marketed from Mar 5, 2014
55111-112-05	55111011205	500 TABLET, FILM COATED in 1 BOTTLE (55111-112-05)Marketed from Mar 5, 2014
55111-112-30	55111011230	30 TABLET, FILM COATED in 1 BOTTLE (55111-112-30)Marketed from Mar 5, 2014
55111-112-66	55111011266	5 BLISTER PACK in 1 CARTON (55111-112-66) / 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-112-79)Marketed from Mar 5, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Moxifloxacin
Generic name (nonproprietary): moxifloxacin
Active ingredients: Moxifloxacin hydrochloride — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Dr. Reddy's Laboratories Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076938
Marketing start: Mar 5, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Quinolones (Chemical structure)
Identifiers: Product ID 55111-112_b7966736-4865-d3ad-d218-886c8a286492SPL ID b7966736-4865-d3ad-d218-886c8a286492SPL set ID 71b02da1-3175-1db8-192a-c0a8a6cd98a5RxCUI 311787UNII C53598599T
Pharmacologic class: Quinolone Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111011201 followed by a unit qualifier and the quantity

Package 55111-0112-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 29, 2020. This label includes a boxed warning.

Indications (excerpt from the label)

Moxifloxacin tablet is a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below: Community Acquired Pneumonia ( 1.1 ) Skin and Skin Structure Infections: Uncomplicated (1.2 ) and Complicated (1.3) Complicated Intra-Abdominal Infections ( 1.4 ) Plague (1.5) Acute Bacterial Sinusitis ( 1.6 ) Acute Bacterial Exacerbation of Chronic Bronchitis (1.7 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin tablets and other antibacterial drugs. Moxifloxacin tablets should be used only to treat or prevent infections that are proven or st…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076938

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076938
Product	Strength	Form · route	Labeler	Product NDC
Moxifloxacin	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-233
Moxifloxacin	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-8357